ZYNERBA PHARMACEUTICALS INC shareholders Q3 2023

ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 44 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

ZYNERBA PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Beryl Capital Management LLC 4,898,927$6,246,1320.70%
Yakira Capital Management, Inc. 620,019$790,5240.22%
Crystalline Management Inc. 230,817$294,2920.21%
DELTEC ASSET MANAGEMENT LLC 475,000$605,6250.14%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 2,283,979$2,912,0730.12%
PenderFund Capital Management Ltd. 123,444$2130.06%
FIFTH LANE CAPITAL, LP 100,000$127,0000.04%
CSS LLC/IL 476,831$607,9600.04%
Penserra Capital Management LLC 220,858$2800.01%
King Wealth Management Group 16,000$200.00%
XTX Topco Ltd 18,793$23,8670.00%
Key FInancial Inc 7,500$9,5620.00%
HRT FINANCIAL LP 203,229$2580.00%
Newbridge Financial Services Group, Inc. 3,610$4,6030.00%
Virtu Financial LLC 13,098$170.00%
Founders Capital Management 2,000$2,5400.00%
Renaissance Technologies 605,700$7720.00%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 37,596$47,7470.00%
MORGAN STANLEY 34,783$44,3490.00%
GHP Investment Advisors, Inc. 1$20.00%
External links

This page lists ZYNERBA PHARMACEUTICALS INC's shareholders in Q3 2023. To view ZYNERBA PHARMACEUTICALS INC's shareholder history, click here.